Risk : Benefit Profile of Etanercept in Elderly Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis

Author： Fleischmann Roy Iqbal Imran

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.3, 2007-01, pp. : 239-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Drugs & Therapy Perspectives, Vol. 26, Iss. 4, 2010-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

By Poddubnyy Denis Rudwaleit Martin

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite

Etanercept: A Review of its Use in the Management of Ankylosing Spondylitis and Psoriatic Arthritis

By Hoy Sheridan M. Scott Lesley J.

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2609-2633

Adis International

Access to resources Recommend Favorite

Etanercept: An Updated Review of its Use in Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Rheumatoid Arthritis

By Culy C.R. Keating G.M.

Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. : 2495-2539

Adis International

Access to resources Recommend Favorite